Headlines about Cerner (NASDAQ:CERN) have trended somewhat positive this week, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cerner earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.8476263439456 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the news headlines that may have impacted Accern’s scoring:
- HIT Think Why the VA should reconsider decision to replace VistA (healthdatamanagement.com)
- Global Blood Bank Information System Market 2018 Report – Cerner Corporation, RoperIndustries and Haemonetics (theanalystfinancial.com)
- $1.34 Billion in Sales Expected for Cerner (CERN) This Quarter (americanbankingnews.com)
- Focus on Unusual Volume Activity Stock – Cerner Corporation (CERN) (wallstreetmorning.com)
- New EHR go-lives, RFIs and other interesting moves so far in April (healthcareitnews.com)
CERN has been the subject of several research analyst reports. Zacks Investment Research cut Cerner from a “buy” rating to a “hold” rating in a research note on Thursday, January 4th. Cantor Fitzgerald reiterated a “buy” rating and set a $80.00 target price on shares of Cerner in a research note on Wednesday, March 14th. BidaskClub cut Cerner from a “hold” rating to a “sell” rating in a research note on Wednesday, January 24th. Evercore ISI initiated coverage on Cerner in a research note on Thursday, January 18th. They set an “in-line” rating and a $77.00 target price for the company. Finally, Royal Bank of Canada reiterated a “buy” rating and set a $76.00 target price on shares of Cerner in a research note on Wednesday, February 7th. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $67.42.
Shares of CERN stock traded up $1.10 on Tuesday, hitting $59.04. 3,198,810 shares of the stock traded hands, compared to its average volume of 2,766,806. The company has a current ratio of 3.01, a quick ratio of 2.99 and a debt-to-equity ratio of 0.11. The firm has a market cap of $18,879.08, a P/E ratio of 26.84, a P/E/G ratio of 1.66 and a beta of 0.96. Cerner has a 1-year low of $55.29 and a 1-year high of $73.86.
Cerner (NASDAQ:CERN) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.61 by ($0.03). The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.61 earnings per share. research analysts forecast that Cerner will post 2.42 EPS for the current fiscal year.
In other Cerner news, Director William D. Zollars sold 4,100 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $62.16, for a total value of $254,856.00. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Vice Chairman Clifford W. Illig sold 307,700 shares of the stock in a transaction on Thursday, March 8th. The stock was sold at an average price of $64.52, for a total value of $19,852,804.00. Following the completion of the sale, the insider now directly owns 1,229,719 shares in the company, valued at $79,341,469.88. The disclosure for this sale can be found here. Over the last three months, insiders have sold 541,800 shares of company stock worth $34,353,860. Corporate insiders own 4.71% of the company’s stock.
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.